Paushak logo

Paushak

PAUSHAKLTD NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹1,801 Cr
Volatility
Moderate
P/E Ratio
42.44
EBITDA
₹72.90 Cr
Return on Equity
8.01%
Debt to Equity
0.16
Book Value
₹199.18
52W High
₹826.75
52W Low
₹342.5

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

4
  • Stock is trading at 3.66 times its book value
  • The company has delivered a poor sales growth of 9.17% over past five years.
  • Company has a low return on equity of 9.58% over last 3 years.
  • Dividend payout has been low at 13.2% of profits over last 3 years

Growth Rate

Revenue Growth
2.44% higher than 3Y
Net Income Growth
-20.45% lower than 3Y
Cash Flow Change
42.72% higher than 3Y
ROE
-24.51% lower than 3Y
ROCE
-22.38% higher than 3Y
EBITDA Margin (Avg.)
-3.69% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
49
52
52
54
52
57
49
52
56
59
49
55
84
Expenses
36
38
33
35
40
40
35
36
38
44
37
38
58
Operating Profit
12
14
19
19
12
17
15
16
18
15
11
17
26
OPM %
25%
28%
36%
35%
23%
30%
30%
30%
32%
25%
23%
30%
31%
Other Income
4
7
3
7
4
4
6
0
2
1
1
8
3
Interest
0
0
0
0
0
0
0
0
0
0
0
1
1
Depreciation
3
3
3
4
4
4
4
4
4
4
5
8
8
PBT
12
18
18
23
12
17
17
12
16
11
7
16
19
Tax %
26%
25%
26%
19%
17%
16%
11%
21%
23%
24%
17%
22%
21%
Net Profit
9
13
14
18
10
14
15
10
12
9
6
13
15
EPS in Rs
3.72
5.42
5.54
7.42
4.19
5.77
6.2
3.9
4.89
3.5
2.5
5.07
6.12
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
69
78
72
105
140
138
141
150
212
206
211
219
246
Expenses
52
61
60
75
99
95
91
96
137
142
151
158
178
Operating Profit
17
17
12
29
40
43
50
54
75
65
60
61
69
OPM %
25%
22%
17%
28%
29%
31%
36%
36%
35%
31%
28%
28%
28%
Other Income
3
3
5
3
13
7
6
5
11
20
14
12
13
Interest
0
0
0
0
0
0
0
0
0
0
0
1
2
Depreciation
2
3
3
3
4
4
5
9
13
14
15
21
26
PBT
18
17
14
29
49
45
52
50
72
71
59
50
54
Tax %
28%
25%
22%
26%
20%
23%
28%
25%
25%
23%
16%
22%
—
Net Profit
13
12
11
21
39
35
37
38
54
54
49
39
42
EPS in Rs
5.07
4.85
4.27
8.39
15.84
14.19
15.16
15.29
21.96
22.09
20.07
15.95
17.19
Div. Payout %
7%
8%
9%
4%
4%
5%
5%
10%
10%
11%
12%
16%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3
3
3
3
3
3
3
3
3
3
3
12
Reserves
54
65
80
110
174
224
269
302
351
405
462
479
Borrowings
0
1
0
1
0
0
0
0
0
0
25
77
Other Liabilities
11
13
11
31
36
43
57
61
61
73
81
92
Total Liabilities
69
82
94
144
214
270
329
367
415
481
572
660
Fixed Assets
18
20
35
37
38
41
51
147
149
152
141
377
CWIP
1
12
0
1
6
16
68
8
7
29
190
26
Investments
19
18
33
53
116
163
154
151
182
223
139
150
Other Assets
30
31
26
54
54
50
56
61
78
77
102
107
Total Assets
69
82
94
144
214
270
329
367
415
481
572
660
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
9
14
12
10
24
41
30
44
43
56
38
54
Investing
-8
-13
-11
-10
0
-39
-29
-42
-38
-50
-57
-95
Financing
-1
-1
-2
-1
-23
-2
-2
-2
-4
-5
19
42
Net Cash Flow
0
0
0
0
0
0
-1
0
0
0
-1
0
Free Cash Flow
0
-3
7
5
13
27
-26
-4
28
17
-122
-34
CFO/OP
77
104
118
56
85
116
85
98
73
107
82
97
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
114
97
83
135
85
69
85
97
90
90
94
92
Inventory Days
96
117
125
118
122
131
148
233
180
177
179
292
Days Payable
94
104
70
170
73
110
118
227
122
130
167
245
Cash Conversion Cycle
116
110
138
83
133
89
115
103
149
137
107
139
Working Capital Days
108
92
92
107
100
75
60
81
93
84
80
64
ROCE %
32%
25%
12%
29%
27%
21%
20%
17%
21%
17%
11%
8%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Paushak insights

63 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Shareholding Pattern

DIIs0.07%Promot.67.28%Others10.16%Public22.49%As ofJun 2026

Documents

Frequently Asked Questions about Paushak

What does Paushak Ltd do?
Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]
Where is Paushak Ltd (PAUSHAKLTD) listed?
Paushak Ltd trades as PAUSHAKLTD on the NSE and under code 532742 on the BSE.
Which sector does Paushak Ltd belong to?
Paushak Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Paushak Ltd?
Paushak Ltd has a market capitalisation of ₹1,801 Cr, which places it in the Small Cap band.
What is the PE ratio of Paushak Ltd?
Paushak Ltd trades at a PE ratio of 42.44, against a book value of ₹199.18 per share.
What is the 52-week high and low of Paushak Ltd?
Over the last 52 weeks Paushak Ltd has traded between ₹342.5 and ₹826.75.
Does Paushak Ltd pay dividends?
Paushak Ltd has a dividend yield of 0.34%.
What is the Return on Equity (ROE) of Paushak Ltd?
Paushak Ltd reported a return on equity of 8.01%. Its debt-to-equity ratio is 0.16.

Company Information

Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]

Website paushak.com
CEO Mr. Chintan Tarunkumar Gosaliya
Employees 380
Listed 2025-12-01
Face Value ₹ 5
Issued Size 2,46,56,912

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PAUSHAKLTD.md for Paushak Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List